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To the Editor: 
The article “Osmolality of Commonly Used Medi- 
cations and Formulas in the Neonatal Intensive Care 
Unit” reports the osmolality ofdrugs, vitamin supple- 
ments, and feeding mixtures used in neonatal inten- 
sive care units (NICUs).’ These osmolalities are 
discussed in terms of risk for necrotizing enterocoli- 
tis (NEC) and other gastrointestinal concerns; how- 
ever, one piece of information was missing. Laboratory 
measures of osmolality of drugs and vitamin supple- 
ments can have little or no relation to the osmotic 
gradient set up across a biological membrane.2 Most 
of the osmolality in a drug or vitamin supplement can 
come from the carrier or stabilizer molecules that 
may or may not diffuse readily across membranes.2 
Osmolality is only a valid measure of risk if the 
molecules set up a n  osmotic gradient across a mem- 
brane in viuo. The osmometer measurement reflects 
the number of particles in the solution, which can be 
made up of both substances that passively diffuse 
across membranes as well as those that do not pas- 
sively diffuse. The piece of missinginformation in the 
article is the type of molecules in the drug and 
vitamin supplement solutions. If the osmolality is 
high from passively diffusing substances, then there 
is no risk; ifit is high from molecules such as a simple 
sugar, there is a risk. 
The authors documented the very high osmolali- 
ties of drugs and vitamin supplements used in the 
NICU. Yet, in spite of these very high osmolalities, 
these mixtures are often well tolerated. There is no 
literature linking a high osmolality of drugs or vita- 
min supplements and NEC. The literature reviewed 
in the article linking osmolality to NEC were ex- 
amples of a sucrose-based calcium lactate formula3 
and a high-osmolality elemental f ~ r m u l a . ~  
Osmolalities of concern are those that are elevated 
from substances that do not passively diffuse across 
membranes, ie, especially sugars, minerals, and 
amino acids. These nutrients can make a large con- 
tribution to osmolality. Glucose polymers and intact 
protein give a lower osmolar load because these 
macromolecules have fewer individual particles. 
Laboratory measures of osmolality from nutrients 
that  do no passively diffuse give a good measure of 
potential risk. Additions of these modulars require 
careful review and guidelines for the NICU. Any drug 
that has a suspension of a sugar syrup or another 
osmotically active substance is also a concern. 
Therefore, the composition of drugs and vitamin 
supplements needs to be known, and the effects of 
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these constituents must be understood to assess 
risk in terms of the osmolality reading. 
Tanis Fenton, MHSc, RD 
Foothills Medical Centre 
Calgary, Alberta, Canada 
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To the Editor: 
The recent Teaching Case publication by Pahwa et 
all presented a challenging and difficult obese patient 
who required prolonged nutrition support secondary 
to multiple medical and surgical complications. We 
have concerns with several points made in this Teach- 
ing Case. The first is the use of albumin (ALB) and 
prealbumin (PAB) to monitor the response to nutri- 
tion. As the authors point out, ALB and PAB are not 
indicative of nutrition response in several clinical 
conditions. In  this Teaching Case, the patient’s serum . 
ALB dropped from admission in the postoperative 
state and continued to decrease after subsequent 
surgeries. PAB levels also remained depressed 
throughout this time period. The investigators attrib- 
uted this response to inadequate nutrition support. To 
the contrary, in this patient experiencing pancreatitis 
and sepsis, two highly stressful conditions, depressed 
PAB levels were due to metabolic stress, with the liver 
reprioritizing visceral protein synthesis? The authors 
even admit that the patient’s PAl3 dropped although 
the patient’s “general condition improved,” demon- 
strating that many factors affect PAB in complicated 
patients. Also fluid shifts in the postoperative state 
are notorious for depressing ALB levels. Therefore, 
these biochemical parameters are not appropriate 
markers for response to nutrition support. In our 
clinical experience, serum ALB and PAB do not in- 
crease until the metabolic stress subsides. 
The use of PAB to monitor nutrition response re- 
sulted in the patient’s receiving approximately 47 
kcaVkg adjusted dry weight and 2.5 g proteinkg 
adjusted dry weight during the 9th and 10th week of 
the hospital stay. At this time, the literature does not 
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support exceeding 35 to 40 kcaVkg and 1.5 to 2 g 
proteinkgin the stressed patient because of the meta- 
bolic derangements that can occur. It is our experience 
that patients, especially obese patients, who receive 
above these recommendations experience hyperglyce- 
mia, hyperuricemia, and hypertriglyceridemia. The 
authors failed to provide these biochemical data in this 
Teaching Case. It would be interesting to know these 
values in a patient experiencing poor wound healing. 
Hyperglycemia and hyperuricemia are known to com- 
promise immune status and impair would healing and 
should be avoided. 
In conclusion, we believe biochemical markers are 
just one of many parameters to monitor in response to 
nutrition support, a point we highly stress in our 
teaching institutions. The use of ALB and PAB to 
monitor the response to nutrition must be used with 
extreme caution in the critically ill patient because 
many nonnutritional factors affect their levels, and 
overfeedingcanoccurwithresultingdetrimentalmeta- 
bolic derangements. 
Theresa L. Han-Markey, MS, RD, CNSD 
Eastern Michigan University, Ypsilanti 
Debbie Lown, MS, RD, CNSD 
University of Michigan, Ann Arbor 
Carol A. Braunschweig, PhD, RD, CNSD 
University of Illinois- Chicago 
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To the Editor: 
The authors thank Han-Markey, Lown, and 
Braunschweig for their comments regarding our 
Teaching Case. As indicated in the case report, 
wound granulation and prealbumin were used as 
indicators of the patient’s response to nutrition sup- 
port. Albumin was not used because it is not an  
indicator of nutritional status or response in the 
critically ill. 
Biochemical indices were monitored to assess any 
metabolic complications as is routinely done at  our 
institution for all patients. Prealbumin was not evalu- 
ated during the patient’s bout with pancreatitis and 
sepsis or immediately after his surgeries. They were 
monitored after the 5th week of hospitalization 
when stress had subsided. A correction is needed to 
clarify that the patient had candida infection in the 
eighth week, not the more stressful sepsis as stated 
in the article. We regret the error and the ensuing 
confusion. As their letter states, this case was very 
difficult because of the large surgical wounds and 
skin breakdown that are hard to heal in such an 
obese individual. During the final septic period prior 
to his demise, prealbumin was not monitored but 
during the period of candida infection, the trend was 
followed along with wound granulation and usual 
biochemical indices. 
The article presents intake based on adjusted 
body weight. Ireton-Jones and Turner’ suggest that 
the use of actual body weight is more appropriate to 
calculate needs for the obese patient. If one calcu- 
lates this patient’s maximum intake during weeks 
9-10 using actual dry weight, the support provided 
was 37.5 kcaVkg and 1.97 g proteinkg/d. This is 
within the ranges recommended by these reviewers 
and others. Even a t  this level of support, the patient 
was losing somatic muscle and fat mass with poor 
wound healing. Measured energy expenditure in the 
obese, nonhospitalized individual is significantly 
higher than nonobese, healthy adults.2 This is prob- 
ably a result of the fact that there is an increase in 
both body cell mass and body fat in obe~i ty .~ .~  
The team monitored the patient for problems 
associated with overfeeding. Uric acid levels re- 
mained within normal range until weeks 17-18 when 
nutritional intake was 29 kcallkg actual weight (102 
kg). After this period the uric acid returned to 
normal. Postoperative pancreatitis was resolved but 
the patient was monitored using triglyceride, amy- 
lase, and lipase values. Triglyceride levels remained 
within an adequate range considering his infectious 
process and liver abcess and serum amylase. Lipase 
levels indicated that there was no recurrent pancre- 
atitis. Prothrombin time and PTT were within nor- 
mal range indicating liver function was adequate for 
synthesis of clotting factors and visceral proteins. 
Blood sugar levels were maintained in the 150-210 
range indicating that this critically ill patient was 
managed conservatively. Thus, biochemical param- 
eters indicated that overfeeding was not a concern. 
We encourage more case reviews of the obese 
patient and nutrition support. We agree that there 
is no “gold s tandard to follow such patients’ nutri- 
tional improvement and wish to add to the body of 
knowledge that can improve the nutritional care of 
these patients. Each obese patient must therefore be 
individually assessed and monitored to provide the 
appropriate nutritional management. 
Neeta Pahwa, MS, RD, CNSb*t 
Ann-Marie Hedberg, DrPH, RD*f 
Branislav Radovancevic, MDT 
Surendra Jain, MD, FACCS 
“St Luke’s Episcopal Hospital 
?Texas Heart Institute 
$Baylor College of Medicine and University of Texas 
Houston, Texas 
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